The activation of immune mechanisms was evaluated by the solid phase enzyme linked immunoassay of immunoglobulin and specific antibody secreting cells in 27 patients (aged from nine to 69 months), subjected to a diagnostic cow's milk challenge or a rechallenge. A significant rise in the total number of immunoglobulin secreting cells was associated with clinically positive (n= 17), but not a negative (n=10) cow's milk challenge in all immunoglobulin isotypes. The number of specific antibody secreting cells against beta lactoglobulin, mean (95% confidence interval), increased from 4-8 (1-4, 15.8) 
Cow's milk allergy has hitherto been considered a temporary condition that improves or disappears with age. Evidence is now accumulating to suggest that this is only partially true, because there is considerable association with other allergic symptoms.' These could manifest themselves either during active cow's milk allergy or later, when clinical tolerance to cow's milk has been acquired. The factors which determine the clinical outcome of cow's milk allergy are not fully understood.
We have previously shown that in cow's milk allergy the immune elimination of cow's milk antigens is deficient. 4 Exposure of the small intestine to cow's milk antigens causes a lesion to the gut mucosa and increases its permeability, permitting the entry of antigens through the impaired host barrier. 6 Sensitisation to unrelated dietary antigens may thus ensue, giving rise to concurrent allergies to other foods.
To date, it is necessary to use clinical criteria for the diagnosis of cow's milk allergy. 7 Cow's milk is eliminated from the diet for a period of time, after which a challenge test is carried out. The disappearance of symptoms during elimination and reappearance on challenge confirm the diagnosis.
The present study was undertaken to evaluate the immune response evoked by such a diagnostic cow's milk challenge. In addition to the immune response to beta lactoglobulin and casein, the fate of an unrelated dietary antigen, gliadin, was studied. For this purpose the ELISPOT assay was used.
Methods

PATIENTS
Altogether 32 children were studied. Of these, 22 had challenge proven cow's milk allergy manifested with either skin (urticaria (four), eczema (10) or gastrointestinal (loose stools) (six), diarrhoea (three), vomiting (two), abdominal pain (three)) symptoms. They were rechallenged to study whether or not clinical tolerance had been acquired. Five patients had experienced symptoms suggestive of cow's milk allergy (urticaria (one), loose stools (one), vomiting (two), diarrhoea (one)) and were admitted for diagnostic milk challenge after four weeks' milk elimination. During the elimination period the patients consumed a tolerated formula (soy or protein hydrolysate) or were given calcium supplementation. Five patients were on a diet devoid of gliadin and they were hence eliminated from the analysis. Four of them had had adverse reactions and in one patient cereals had not yet been introduced to the diet.
The study population thus consisted of 27 patients aged from nine to 69 months. Fourteen of these patients had dietary restrictions for egg (three), citrus fruits, peanuts, and fish (11) because of adverse reactions.
MILK CHALLENGE PROTOCOL
The challenge was started with a drop of cow's milk on the lips, whereafter milk was given in rising doses at two hour intervals. On day 1, 2, 5, 10, 20, 50, and 100 ml of milk were given and on day 2 the normal milk intake appropriate for age was started. The challenge was stopped and the patients were examined, when any adverse reaction was noted. The reaction onset time was defined as the duration from the last given dose eliciting the symptoms. The patients were followed up over the one week period of the challenge and, for longterm tolerance; they were seen one month later. (Table I ). In addition, they often reacted immediately, while gastrointestinal symptoms were commonly manifested later.
The mean (SD) ages of the patients positive, 20-1 (7.9) months, and negative, 29-4 (16-1) (1) and after (2) There was a statistically significant increase in the number of immunoglobulin secreting cells from day 1 to day 8 in patients with positive clinical reaction to challenge (Fig 1) . By contrast, in patients negative to challenge the mean * number of immunoglobulin secreting cells decreased during the challenge period (Fig 2) . (Table II) . A distinct rise in the number of specific antibody secreting cells to beta lactoglobulin and casein was detected in patients reacting positively to challenge in the IgM class (Fig 3) . Conversely, the specific antibody secreting cell responses from day The patients positive to cow's milk challenge also mounted a specific antibody secreting cells response against gliadin in the IgM class (Fig 3) , which was not seen in patients negative to challenge (Fig 4) . The ANOVA for repeated measures showed significant interaction (p= 0 002) between groups and periods, indicating that the differences at successive measurements of IgM specific antibody secreting cells to gliadin between patients positive and negative to challenge were statistically significant.
Discussion
The results of the present investigation agree with those of previous studies indicating that immune mechanisms are activated in cow's milk allergy,4 10 and further extend these findings to unrelated dietary antigens encountered by the enteral route.
We used a new immunoassay, the ELISPOT, to measure immune response during cow's milk challenge. The ELISPOT is a promising method for indirect study of the immunologic events in the gut.8' The method is based on the maturation cycle of gut associated lymphoid tissue derived lymphocytes. After contact with intraluminal antigens, the lymphocytes travel to mesenterial lymph nodes to mature and by way of peripheral blood back to the gut mucosa to secrete antibodies against the priming antigen." 1 The cell migration cycle is based on experimental work in animal studies as well as in human studies of oral vaccination.89 [11] [12] [13] Evidence in support of the concept has been provided by adoptive transfer experiments in which B-lymphocytes from mucosa associated lymphoid tissues have been shown to repopulate the mucosa.'4 ' The intensity of the immune response as measured by the ELISPOT correlates with the capability of the antigen of adhering to the epithelial cells. 16 In the present study a sharp rise in immunoglobulin secreting cells was measured during a clinically positive milk challenge, reflecting nonantigen specific immune response. At the same time, the antigen specific immune response was small and inconsistent. This indicates that immune system elimination of cow's milk antigens is defective in cow's milk allergy. In a previous follow up study we The final result of the immune mediated tissue damage may include mucosal edema, commonly associated with type 1 hypersensitivity, or villus effacement and crypt hyperplasia associated with cell mediated reactions.'9 In patients who have cow's milk allergy, a clinically positive milk challenge induces the increased permeability of gut mucosa, irrespective of whether the symptoms arise from the gut or the skin.9 This is in support of the notion that deranged intestinal barrier is not primary to the allergic state, but rather secondary to the hypersensitivity reaction.
Although the intestinal hypersensitivity reaction is highly specific to the priming antigen, the resulting enhancement of permeability is not necessarily antigen specific. On account of that, there is enhanced absorption of unrelated intraluminal antigens during a positive cow's milk challenge. The sharp rise in the number of specific antibody secreting cells against gliadin may hence reflect increased antigenic load caused by the immune-mediated lesion in the gut mucosa. Repetition of such hypersensitivity reaction could result in broadening of allergic symptomatology.
The clinical implication of this study is that appropriate dietary elimination is crucial in the treatment of patients who have cow's milk allergy. Furthermore, the question remains how frequently clinical challenges are needed to support the diagnosis and how often the challenges can be carried out without impairing the prognosis of the disease.
